With a focus on actionable insights and strategic value, The Business Research Company’s 2026 market reports include market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.
Computational Biology Market Size Outlook: A $27.32 Billion Market By 2030, Growing At 23.7% Annually
The computational biology market has seen substantial exponential growth in recent years. It is forecast to increase from $9.47 billion in 2025 to $11.68 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 23.4%. This historical growth can be attributed to advancements in genomic sequencing technologies, the increased availability of biological datasets, growing collaboration between biology and computer science, the expansion of academic bioinformatics research, and the early adoption of computational modeling in life sciences.
The computational biology market is projected to experience substantial growth in the upcoming years. It is anticipated to expand to $27.32 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 23.7%. This expansion throughout the forecast period can be attributed to various factors, including the increasing demand for precision medicine solutions, greater investments in drug discovery analytics, the proliferation of cloud-based bioinformatics platforms, the growing implementation of AI-driven biological insights, and a heightened reliance on data-driven clinical research. Key trends anticipated during this period include the rising use of algorithm-driven biological modeling, increasing adoption of in-silico drug discovery tools, the deepening integration of multi-omics data analysis, the expansion of high-performance computing in biology, and an enhanced focus on predictive biological simulations.
Make Data-Driven Decisions With A Free Computational Biology Market Sample Report:
Key Demand Driver Expected To Lift Computational Biology Market Revenue
The rising need for individualized medical approaches is projected to stimulate the growth of computational biology. Personalized medicine, also known as precision medicine, represents a healthcare strategy that accounts for each patient’s unique genetic characteristics, environmental influences, and lifestyle when designing treatment regimens. This method relies on analyzing an individual’s genetic information to customize medical interventions. Computational biology is essential for interpreting this genetic data, enabling the development of targeted therapies, optimizing treatment protocols, and predicting patient outcomes. Furthermore, it helps classify patients into specific subgroups, reduces healthcare expenditures, and conforms to regulatory and clinical guidelines. For instance, in February 2024, the Personalized Medicine Coalition, a US-based advocacy group for tailored medical treatments, stated that the FDA approved 16 new personalized treatments for rare disease patients in 2023, which was an increase from six in 2022. Thus, the escalating demand for personalized medicine is propelling the expansion of the computational biology market.
Exploring The Computational Biology Market Through Its Key Segments
The computational biology market covered in this report is segmented –
1) By Services: In-house, Contract
2) By Tools: Databases, Infrastructure (Hardware), Analysis Software and Services
3) By Application: Cellular and Biological Simulation, Drug Discovery and Disease Modelling
4) By End User: Research, Pharmaceutical Industry, Commercial Applications
Subsegments:
1) By In-house: Data Analysis, Software Development, Research And Development
2) By Contract: Outsourced Bioinformatics, Collaborative Research, Data Management Services
New Trends Redefining Competition In The Computational Biology Market
Leading companies in the computational biology market are actively developing novel solutions for proteomics research to gain a competitive edge. Proteomics research itself is a scientific discipline focused on the thorough analysis of proteins within a biological system. For instance, in May 2023, Biognosys AG, a biotechnology company based in Switzerland, unveiled Spectronaut 18, introducing significant scientific and technological enhancements for its proprietary proteomics research software and offerings. Spectronaut 18 provides high throughput and efficiency in data-independent acquisition (DIA) proteomics analysis. The company’s TrueDiscovery platform enhances biomarker discovery in fields such as oncology and neuroscience by offering exceptional depth and sensitivity in proteomics. Additionally, TrueTarget facilitates high-resolution drug target identification and deconvolution, and Biognosys’ iRT Kit, recommended for real-time system suitability monitoring, is now compatible with Bruker ProteoScape software.
Computational Biology Market Competition: Key Players And Industry Participants
Major companies operating in the computational biology market are Certara L.P.; Chemical Computing Group Inc.; Compugen Ltd.; Genedata AG; Dassault Systèmes SE; Rosa & Co. LLC; Simulation Plus Inc.; Nimbus Discovery LLC; Rhenovia Pharma SAS; DNAnexus; Genialis Inc.; BC Platforms; Schrodinger Inc.; Strand Life Sciences; Numerate Inc.; Insitro; Recursion Pharmaceuticals; Atomwise; Relay Therapeutics; Exscientia
Get The Detailed Computational Biology Market Research Report Here:
Computational Biology Market Regional Overview: Largest Market And Global Coverage
North America was the largest region in the computational biology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the computational biology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
